Anja Pfalzgraff

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The stagnation in the development of new antibiotics and the concomitant high increase of resistant bacteria emphasize the urgent need for new therapeutic options. Antimicrobial peptides are promising agents for the treatment of bacterial infections and recent studies indicate that Pep19-2.5, a synthetic anti-lipopolysaccharide (LPS) peptide (SALP),(More)
  • 1